Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Infectious Diseases and Their Occurrence

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable...

Viral Recombination

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Less is more: modelling the impact of species-targeted versus broadcast larviciding in Anopheles funestus-dominated malaria transmission settings.

Malaria journal·2026

Same author

Clinical validation of tissue and liquid companion diagnostics for BRAF V600E detection in non-small cell lung cancers from the PHAROS study.

Cancer research communications·2026

Same author

The origin, history, and resistance architecture of an invasive urban malaria mosquito in Africa.

Science (New York, N.Y.)·2026

Same author

Pan-tumor validation of FoundationOne<sup>®</sup>CDx as a companion diagnostic for <i>RET</i> fusions as a predictor of response to selpercatinib.

Frontiers in oncology·2026

Same author

Impact of a one-year interruption to vector control on Bioko Island, Equatorial Guinea.

Malaria journal·2026

Same author

Projected impacts of climate change on malaria in Africa.

Nature·2026

Same journal

Therapeutic activation of PPARα contributes to NOTCH1 inhibition in T-cell acute lymphoblastic leukemia.

BMC medicine·2026

Same journal

Social vulnerability index and inflammation: a proteomic analysis linking social context to biological risk in older black adults.

BMC medicine·2026

Same journal

Efficacy of remote ischemic conditioning on cerebral blood flow regulation in patients with endovascular stenting: a randomized controlled trial.

BMC medicine·2026

Same journal

Brief digital narrative intervention for adolescent depression, anxiety, and insomnia during academic stress: a cluster randomized controlled trial.

BMC medicine·2026

Same journal

Effect of Vitamin C on bleeding and pain after kidney biopsy: a randomized controlled trial.

BMC medicine·2026

Same journal

Impact of gestational diabetes on future diabetic retinopathy and microvascular complications: a nationwide cohort study.

BMC medicine·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Apr 1, 2026

Bidirectional Retroviral Integration Site PCR Methodology and Quantitative Data Analysis Workflow

Bidirectional Retroviral Integration Site PCR Methodology and Quantitative Data Analysis Workflow

Published on: June 14, 2017

Integrating vector control across diseases.

Nick Golding¹, Anne L Wilson², Catherine L Moyes³

¹Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK. nick.golding.research@gmail.com.

|October 2, 2015

Summary

This summary is machine-generated.

Integrating vector control programs for multiple vector-borne diseases offers a cost-effective strategy for disease reduction. Over half the global population faces risk from at least two such diseases, highlighting the potential for combined interventions.

More Related Videos

Site-Directed φC31-Mediated Integration and Cassette Exchange in Anopheles Vectors of Malaria

Site-Directed φC31-Mediated Integration and Cassette Exchange in Anopheles Vectors of Malaria

Published on: February 2, 2021

Chitosan/Interfering RNA Nanoparticle Mediated Gene Silencing in Disease Vector Mosquito Larvae

Chitosan/Interfering RNA Nanoparticle Mediated Gene Silencing in Disease Vector Mosquito Larvae

Published on: March 25, 2015

Related Experiment Videos

Last Updated: Apr 1, 2026

Bidirectional Retroviral Integration Site PCR Methodology and Quantitative Data Analysis Workflow

Bidirectional Retroviral Integration Site PCR Methodology and Quantitative Data Analysis Workflow

Published on: June 14, 2017

Site-Directed φC31-Mediated Integration and Cassette Exchange in Anopheles Vectors of Malaria

Site-Directed φC31-Mediated Integration and Cassette Exchange in Anopheles Vectors of Malaria

Published on: February 2, 2021

Chitosan/Interfering RNA Nanoparticle Mediated Gene Silencing in Disease Vector Mosquito Larvae

Chitosan/Interfering RNA Nanoparticle Mediated Gene Silencing in Disease Vector Mosquito Larvae

Published on: March 25, 2015

Area of Science:

Global Health
Infectious Diseases
Vector Control

Background:

Vector-borne diseases represent over 10% of the global infectious disease burden.
Limited resources hinder effective control of many vector-borne diseases.
Existing vector control methods often target multiple diseases, suggesting integration potential.

Purpose of the Study:

To assess the feasibility and potential benefits of integrated vector control programs.
To identify opportunities for combining vector control strategies across multiple diseases.
To quantify the overlap in population risk for major vector-borne diseases.

Main Methods:

Utilized high-resolution global maps of major vector-borne pathogens to determine distribution overlaps.
Assessed the overlap of vector control methods effective against co-endemic diseases.
Analyzed population at risk for single and multiple vector-borne diseases.

Main Results:

Over 80% of the global population is at risk of at least one vector-borne disease.
More than half the world's population is at risk from at least two vector-borne diseases.
Malaria, leishmaniasis, lymphatic filariasis, and dengue show significant distribution overlap and susceptibility to common control methods.

Conclusions:

Cross-disease vector control, exemplified by integrated vaccine and drug administration programs, offers a precedent for sustainable disease reduction.
While large-scale trials are pending, existing evidence suggests integrated vector control can maximize health benefits within limited budgets.
Targeted integration of vector control for diseases like malaria, leishmaniasis, lymphatic filariasis, and dengue is a promising strategy.